The process of cancer cell invasion involves degradation of the extracellular matrix (ECM) by proteases, integrin adhesion and cell motility. The role of ECM degrading proteases on the hypoxia-induced invasion of breast carcinoma cells was investigated. Hypoxia markedly increased the invasion capacity of MDA-MB-231 and MDA-MB-435 breast carcinoma cell lines. Matrix metalloproteinase (MMP) inhibitors blocked the hypoxia-induced invasion, whereas other protease inhibitors had no effect. Antibodies or siRNAs blocking either membrane type-1 MMP (MT1-MMP) or MMP-2 were effective in reducing the hypoxia-induced invasion. Serumfree reconstitution experiments confirmed the involvement of the MT1-MMP/MMP-2/tissue inhibitor of metalloproteinase-2 complex in this hypoxia-induced response. Overexpression of MT1-MMP in a poorly invasive breast cancer cell line, T47-D, promoted hypoxia-induced invasion and MMP-2 activation. Cell surface accumulation and activation of MT1-MMP without apparent regulation at the mRNA or protein levels indicated a post-translational adaptive response to hypoxia. Inhibition of the small GTPase RhoA eliminated the hypoxiainduced invasion and blocked the localization of MT1-MMP to the plasma membrane. Zymographic and molecular analysis of human breast tumors showed a strong correlation between hypoxic microenvironments and MMP-2 activation without changes in MT1-MMP expression. Our studies suggest that hypoxic tumor microenvironments promote breast cancer invasion through an MT1-MMP-dependent mechanism.
Introduction
Matrix metalloproteinases (MMPs) are zinc-binding endopeptidases capable of degrading most of the components of the extracellular matrix (ECM) including the basement membrane (BM). Normally, they are expressed during embryonic stages and during processes of tissue remodeling, such as ovulation, endometrial cycling and wound healing (Nagase and Woessner, 1999; Brinckerhoff and Matrisian, 2002) . MMPs are frequently overexpressed in a variety of human tumors (Edwards and Murphy, 1998; Egeblad and Werb, 2002) and are recognized as important players in many steps of the metastatic process (Freije et al., 2003; Yoon et al., 2003; DeClerck et al., 2004) . In breast cancer, as well as in many other cancers, increased MMP expression and activation correlates with increased metastatic potential and poor prognosis (Ishigaki et al., 1999; Jones et al., 1999; Duffy et al., 2000) . MMPs contribute to invasion and metastasis of tumor cells facilitating the degradation of the surrounding BM and ECM barriers, allowing migration and spreading of cancer cells (Chang and Werb, 2001) . They are also involved in the regulation of cell proliferation, release of growth factors and angiogenesis (Nelson et al., 2000; Stetler-Stevenson and Yu, 2001 ). MMP activity is regulated at several levels, most notably, by the proteolytic cleavage of inactive proforms into mature active forms and by interaction with the endogenous tissue inhibitors of metalloproteinases (TIMPs) (Nagase and Woessner, 1999) .
MMPs can be classified into secreted MMPs and membrane-associated MMPs based on their structure. While secreted MMPs can diffuse and affect distant tissues and cells, membrane-type MMPs (MT-MMPs) are restricted to the plasma membrane of the cells that produce them and, therefore, regulate proteolytic activity in their close surroundings (Sato et al., 1994; Seiki, 2002) . Membrane type-1 (MT1)-MMP (MMP-14) was first identified as a protease that converts pro-MMP-2, a type IV collagenase/gelatinase A, to its mature form. It also cleaves a number of ECM substrates including collagens I, II and III, fibronectin and laminins (Kinoshita et al., 1996; d'Ortho et al., 1997; Lehti et al., 1998; Udayakumar et al., 2003) . The activation of MMP-2 occurs in a cell surface activation complex consisting of MT1-MMP, TIMP-2 and pro-MMP-2 (Lehti et al., 1998; Zucker et al., 1998; Itoh et al., 2001) . According to this model, pro-MMP-2 activation occurs at limited concentrations of TIMP-2, whereas excess TIMP-2 is inhibitory. The role of MT1-MMP/TIMP-2/MMP-2 complex in different cancers has been evaluated by quantification of MMP expression or by measuring MMP-2 activity in different types of tumors, including those of the breast (Ueno et al., 1997; Mimori et al., 2001; Giannelli et al., 2002; Zhai et al., 2005) . Many of these studies show a pattern of increased MT1-MMP expression with concomitant MMP-2 activation.
MT1-MMP expression and activity at the cell surface is a highly regulated process. MT1-MMP activation pathways have been demonstrated by concavalin A stimulation, cytokine treatments and chemokine exposure (Yu et al., 1997; Sameshima et al., 2000; Bartolome et al., 2004) . Proper localization and trafficking of MT1-MMP to the plasma membrane are also very important mechanisms of functional regulation (Mori et al., 2002; Remacle et al., 2003; Rozanov et al., 2004; Wang et al., 2004) . Since it is possible that numerous factors control MT1-MMP expression and function, we examined whether hypoxia, a critical tumor microenvironmental stress, could influence the ability of breast cancer cells to activate MMP-dependent invasive mechanisms.
Hypoxia alters important intracellular pathways and is recognized as a stimulus for tumor angiogenesis and metastasis (Semenza, 2002; Subarsky and Hill, 2003; Vaupel, 2004) . Interestingly, many reports have linked hypoxia with the regulation of expression and/or activity of members of the MMP family, including MT1-MMP (Canning et al., 2001; Burke et al., 2003; Brat et al., 2004; Fahling et al., 2004; Ridgway et al., 2005) . However, some of these reports are contradictory, and tumor-and cell type-specific constraints may exist. Therefore, we examined the role and the mechanism for MT1-MMP function in the hypoxiainduced invasion of breast carcinoma cells through a BM barrier and in tumor microenvironments.
Results
Hypoxia potentiates breast cancer cell chemoinvasive activity through MMP activation To examine whether hypoxia could influence the ability of breast cancer cells to activate proinvasive protease cascades, the estrogen-receptor-negative, highly invasive breast cancer cell lines MDA-MB-435 and MDA-MB-231 were subjected to invasion assays using a BM barrier composed mainly of laminin and collagen IV (Matrigel). Cells were allowed to invade under normoxic or hypoxic conditions for 24 h in a 1-10% serum gradient. The effect of hypoxic culture conditions on breast cancer cell invasion was dramatic in both cell lines, showing a significant 3-4-fold increase of invasion over normoxic controls (Figure 1a ). MDA-MB-231 cells showed a slightly higher level of hypoxia-induced invasion than MDA-MB-435, and therefore were used for additional mechanistic studies.
To evaluate the potential contribution of different ECM-degrading proteases in the hypoxia-induced invasion of MDA-MB-231 cells, a number of inhibitors were employed. All the inhibitors were used at the maximal doses determined not to affect cell viability when used under hypoxia for 24 h. The broad-spectrum MMP inhibitor llomastat (GM6001) was effective in blocking hypoxia-induced invasion. The inhibition of invasion over a 24 h period was found to be dose dependent and the hypoxic induction was nearly eliminated with highdose llomastat (2.5 mM). Inhibitors targeting serine, amino, and cysteine proteases; aprotinin, bestatin and E64, respectively, were ineffective in blocking the hypoxic response (Figure 1b) . Interestingly, aprotinin and E64 partially repressed invasion under normoxic conditions, whereas llomastat and bestatin had partial effects that were not significant (data not shown). These data support the hypothesis that MMP activation cascades are essential to the hypoxia-induced invasive capacity of breast carcinoma cells. Llomostat (L) inhibits MDA-MB-231 hypoxiainduced invasion in a dose dependent manner, 0.5 and 2.5 mM. The protease inhibitors aprotinin (Ap), bestatin (Be) and E64 were used for 24 h at 0.25 mM, 40mM and 10 mM, respectively. Statistically significant differences at Po0.005 from the hypoxic control (H) are indicated (*).
Hypoxia-induced invasion is dependent on the MT1-MMP/MMP-2/TIMP-2 axis To address which MMPs might be contributing to the hypoxia-induced invasive process, we blocked MMPs using specific antibodies and TIMPs. The effect of adding antibodies against MT1-MMP, MMP-2 and aminopeptidase N/CD13, and the selective inhibitors TIMP-1 and TIMP-2 to MDA-MB-231 cells during the invasion assay in the presence of serum, is shown in Figure 2a . Anti-MT1-MMP and anti-MMP-2 antibodies significantly repressed cell invasion under hypoxic but not under normoxic conditions. Excess TIMP-2, which effectively inhibits MMP-2 and MT1-MMP (Lambert et al., 2004) , also blocked the hypoxia-induced invasion. TIMP-1, a tissue inhibitor of MMPs that does not inhibit MT1-MMP (Lambert et al., 2004) , partially repressed the invasion in normoxic and hypoxic conditions to approximately 50-60% of the normoxic and hypoxic controls. As a control, the inhibitory antibody against the cell surface aminopetidase N/CD13 (Sato, Figure 2 Hypoxia-induced invasion requires MT1-MMP, pro-MMP-2 and TIMP-2. (a) MDA-MB-231 cell invasion assays performed under normoxia (&) or hypoxia (') for 24 h. Antibodies (20 mg/ml), or TIMP-1 (12 nM) were mixed with cells prior to seeding on Matrigel. Statistically significant differences from untreated hypoxia control (À) are indicated for Po0.005 (*). (b) Gelatin zymography of conditioned media from upper chambers of invasion assays described in (a). Bands corresponding to gelatinolytic activity of pro-MMP-2 and MMP-2 are indicated. (c) Serum-free reconstitution of hypoxia-induced invasion. MDA-MB-231 cells were applied to Matrigel in DMEM alone (À) or containing pro-MMP-2 (14 nM), TIMP-2 (12 nM) or a combination of both at different molar ratios. Statistically significant differences from untreated hypoxia control are indicated for Po0.005 (*).
2003) had no effect on cell invasion. These results indicate a clear role for both MT1-MMP and MMP-2 in the hypoxia-dependent invasion.
Gelatin zymography analysis was used to examine MT1-MMP activity by measuring its ability to convert pro-MMP-2 into active MMP-2. Active MMP-2 is visualized as a clear band at 67 kDa as a result of gelatinolytic activity. Gelatin zymography analysis of conditioned media from the top chamber of invasion assays described in Figure 2a clearly indicates that MMP-2 activation is significantly increased in hypoxia. MMP-2 activation was blocked by antibodies to MT1-MMP and MMP-2, and by addition of excess TIMP-2 (Figure 2b ). MMP-9 activity was also assessed by gelatin zymography. Bands corresponding to pro-MMP-9 and active MMP-9 were constitutively present under both normoxic and hypoxic conditions without any apparent change (data not shown). Thus, MMP-2 activation correlates with the hypoxia-induced response.
Serum is well documented to contain detectable levels of pro-MMP-2 (Cao et al., 1995) . Therefore, to clearly define the necessary components involved in the hypoxia-induced invasion, serum-free reconstitution experiments were performed. Serum-free conditions do not support hypoxia-induced invasion of MDA-MB-231 cells (Figure 2c ). MDA-MB-231 cells express little pro-MMP-2 and TIMP-2 as determined by quantitative RT-PCR (qRT-PCR) and ELISA of conditioned media (data not shown). Therefore, the requirement for pro-MMP-2 and TIMP-2 was tested by supplementing the cells with each alone, or in combination. The addition of recombinant pro-MMP-2 (14 nM) significantly increased the number of invading cells under hypoxic conditions to at least two-fold. TIMP-2 addition alone showed a moderate decrease in both the normoxic and hypoxic invasion when used at 12 nM. Interestingly, when pro-MMP-2 was combined with TIMP-2 at a 1:0.3 molar ratio, a recovery of the hypoxia-induced invasion was observed as a three-fold increase over the normoxic control containing both components. Addition of TIMP-2 in a molar ratio three times higher than MMP-2 completely blocked the hypoxia-induced invasion (Figure 2c ). These findings indicate that low concentrations of TIMP-2 relative to MT1-MMP/ MMP-2 are needed to induce maximal response. These data support the hypothesis that extracellular pro-MMP-2 and TIMP-2 together with cell surface MT1-MMP define the minimal essential components for the hypoxia-induced invasion. The basal levels of invasion observed under normoxic or hypoxic conditions may be due to the constitutive expression of other proteases such as MMP-9.
Inhibition of MT1-MMP by RNA interference blocks the hypoxia-induced invasion To confirm the specific requirement for MT1-MMP function in the hypoxia-induced invasion, MDA-MB-231 cells were transfected with siRNA oligos against MT1-MMP. qRT-PCR analysis showed a significant repression of MT1-MMP mRNA by the siRNA treatment ( Figure 3a ). Protein levels were also repressed, as shown by the MT1-MMP immunoblot ( Figure 3b ). The inhibition of MT1-MMP drastically blocked hypoxia-induced invasion in the presence of serum, while mock transfection did not affect the hypoxic response ( Figure 3c ).
The specific inhibition of MT1-MMP by siRNA also resulted in the repression of MMP-2 activation as shown by gelatin zymography of conditioned media from transfected cells placed in normoxic or hypoxic conditions ( Figure 3d ). These data confirm the results obtained using blocking antibodies and the reconstitution experiments. Together, these experiments demonstrate that endogenous MT1-MMP is required for hypoxia-induced MMP-2 activation and invasion. (Figure 5a ). Hypoxic induction of glucose transporter 1 (Glut-1) mRNA was observed. Glut-1 is a hypoxia-inducible gene and serves as an internal control for hypoxia treatment in this experiment (Subarsky and Hill, 2003) . In addition, immunoblot analysis of total cell lysates from either MDA-MB-435 or MDA-MB-231 cells subjected to 24 h of normoxic or hypoxic culture conditions showed no apparent differences in MT1-MMP expression ( Figure 5b ).
Hypoxia induces cell surface localization of MT1-MMP
The effect of hypoxic conditions on MT1-MMP localization was examined by surface immunofluorescence analysis of MDA-MB-231 cells. Cells were labeled with MT1-MMP antibodies at 41C to prevent internalization and to selectively label surface MT1-MMP. When compared to cells exposed to normoxic conditions, hypoxia-treated cells presented a dramatic induction of cell surface MT1-MMP (Figure 6a ). Cells treated with hypoxic conditions showed 8-10 times more staining of cell surface MT1-MMP than normoxic cells, as determined by quantification of MT1-MMP immunofluorescent signal. To examine the localization of MT1-MMP and TIMP-2 with respect to hypoxia-induced invadopodia on breast cancer cells, MDA-MB-231 cells were evaluated for cell surface localization by immunoelectron microscopy ( Figure 6b ). Cells were plated on Matrigel-coated transwell chambers, exposed to normoxic or hypoxic conditions and immunostained for cell surface MT1-MMP and TIMP-2 using specific primary antibodies and secondary antibodies coupled to different size gold particles: 10 nm for anti-MT1-MMP and 5 nm for anti-TIMP-2. Hypoxia-treated cells showed a multitude of invadopodial projections of approximately 400 nm in diameter, with 80 nm bridging connections to the cell body. These projections were mostly absent in cells plated under normoxic conditions. Hypoxia-treated cells also showed the presence of both large and small gold particles corresponding to MT1-MMP and TIMP-2, respectively. Higher magnification micrographs (Figure 6b , lower panel) clearly showed the localization of both large and small gold particles on the same invadopodia, as well as clusters that have multiple particles.
The MT1-MMP particles were distinctly localized to the outer edge of the hypoxia-induced invadopodia and the total number of MT1-MMP-positive signals was selectively higher in hypoxic samples compared to normoxic ones when multiple sectional areas were quantified: 13.6771.71 vs 0.3370.21 particles/3 mm cell surface cross section (ave.7s.e.m., n ¼ 6), P ¼ 0.0022, hypoxic vs normoxic conditions, respectively. TIMP-2 signal was also found to increase at the cell surface of hypoxia-treated cells, but was not statistically significant due to large sample variance: 17.6772.69 vs 8.0074.93 particles/3 mm cell surface cross-section (ave.7s.e.m., n ¼ 6), P ¼ 0.116, hypoxic vs normoxic conditions, respectively.
To biochemically confirm the dramatic hypoxic induction of MT1-MMP localization to the cell surface determined by immunological methods, cell surface biotinylation and MT1-MMP detection under normoxic or hypoxic conditions were performed (Figure 6c ). Surface biotinylation of MDA-MB-231 cells followed by MT1-MMP immunoprecipitation and streptavidin detection showed increased amounts of surface MT1-MMP under hypoxic conditions (Figure 6c, upper panel) . Total cell surface biotinylated protein was also captured with streptavidin agarose affinity beads and then Glut-1 was detected (Figure 6c , middle panel). Increased Glut-1, a hypoxia-inducible membrane protein, confirmed the efficacy of the hypoxic treatment. Detection of the epithelial membrane antigen (EMA) was used as a cell surface marker (Sloane and Ormerod, 1981) and loading control, showing similar levels of surface expression under both normoxic and hypoxic conditions (Figure 6c, lower panel) . These experiments show that hypoxia induces localization of MT1-MMP to the plasma membrane. Once on the cell surface, MT1-MMP is able to activate MMP-2 and induce invasion.
Role of small GTPases in the hypoxia-induced invasion
To further evaluate the intracellular mechanisms responsible for the hypoxia-induced invasion and translocation of MT1-MMP to the plasma membrane, involvement of the small GTPase family of proteins was tested. Small GTPases are involved in the motility of a variety of carcinoma cell lines and have recently emerged as important control elements of vesicular trafficking (Oxford and Theodorescu, 2003; Symons and Rusk, 2003) . Hypoxic culture conditions induced the activation of Rho in MDA-MB-231 cells, as shown by the binding of active RhoA (GTP-RhoA) to a Rhotekin-GST construct as early as 6 h, persisting through 24 h (Figure 7a ). To test the potential role of RhoA in cellular responses to hypoxia, dominant-negative forms of RhoA and Rac-1 were expressed in MDA-MB-231 cells by adenoviral transduction. The expression of the dominant-negative forms was confirmed by immunoblot analysis (Figure 7b) . Expression of dominant-negative RhoA was effective in repressing the hypoxia-induced invasion, whereas dominant-negative Rac1 inhibited invasion under both, normoxic and hypoxic conditions, to approximately 50% of the Tet repressor controls (Figure 7c) . Furthermore, the expression of the dominant-negative form of RhoA significantly decreased the localization of MT1-MMP to the plasma membrane when cells were analysed by immunofluorescent labeling of surface MT1-MMP (Figure 7d ). These data support the hypothesis that hypoxia promotes RhoA-dependent trafficking of MT1-MMP to the plasma membrane.
MMP-2 activation in human breast cancer samples correlates with the hypoxic regions of the tumor To test the hypothesis that tumor microenvironments contribute to MT1-MMP activity, we examined the level of activated MMP-2 in hypoxic vs nonhypoxic/vascular regions of primary human breast tumors. Table 1 shows the clinical characteristics of the breast cancer cases used for this study. After rapid procurement (o10 min), breast tumor samples were frozen in cryogenic freezing media and cryosections analysed for CD31/PECAM-1 as a vascular density marker, and for carbonic anhydrase IX (CA-IX) as a surrogate marker for hypoxic regions (Subarsky and Hill, 2003) . Regions with strong CD31 were defined as vascular, nonhypoxic areas (V), while regions with high levels of CA-IX staining were defined as hypoxic areas (H). Vascular and hypoxic areas from the same tumor were overlaid onto the frozen specimen and the tissue was cored. Figure 8a shows a representative example of a tumor sample where one vascular and two hypoxic areas were selected by immunohistological staining.
Tumor core protein lysates from the vascular or hypoxic microenvironments were used for gelatin zymography to evaluate MMP-2 activity and for immunoblotting of total MT1-MMP levels. Gelatin zymography from four different tumor samples with their respective vascular and hypoxic regions are shown in Figure 8b . The levels of low-molecular-weight, active MMP-2 in each of the samples were higher in the hypoxic regions compared to the highly vascularized areas. However, the levels of total MT1-MMP protein were similar when the vascular and hypoxic areas were compared by direct immunoblot. Interestingly, there was significant variation in the total level of MT1-MMP expression among the different tumor samples ranging from low to high (i.e. tumor 19 compared to tumor 30).
Immunohistochemistry of a representative tumor section showed that MT1-MMP staining in hypoxic regions was extended throughout the cell to the plasma membranes within tight cell clusters, while vascular regions showed punctate staining in the cytoplasm of the cells, covering the nucleus (Figure 8c) .
A total of 15 tumor samples were analysed for vascular and hypoxic markers. Only a third of them showed differential microenvironments amenable for excisional coring and follow-up protein and zymography analysis. These observations indicate that, for tumors containing complex microenvironments, MMP-2 activation can be dramatically heterogeneous despite similar levels of total MT1-MMP expression by tumor cells.
Discussion
Clinical and experimental data have provided evidence for an association between the hypoxic tumor microenvironment and metastatic disease (Subarsky and Hill, 2003) . At the cellular level, hypoxia induces changes that lead to cell survival, angiogenesis and invasion (Vaupel, 2004 ). Several studies have described the transcriptional upregulation of proteases and protease receptors, such as MMP-9 and urokinase-type plasminogen activator receptor (uPAR), as mechanisms involved in the hypoxia-induced cell invasion (Graham et al., 1999; Canning et al., 2001; Krishnamachary et al., 2003) . However, we have identified the post-translational regulation of MT1-MMP as a novel mechanism for the hypoxia-induced invasion of breast carcinoma cells.
We have shown that the invasion potential of MT1-MMP-expressing breast cancer cell lines through a BM barrier was dramatically increased by hypoxia. Experiments using MMP inhibitors, target-specific antibodies and RNA interference showed that the hypoxia-induced invasive activity was dependent upon activated MT1-MMP and required pro-MMP-2. pro-MMP-2 is expressed at very low levels under normoxic and hypoxic conditions by MDA-MB-231 cells. The addition of recombinant pro-MMP-2 to serum-free invasion assays resulted in a partial recovery of the hypoxia-induced response in MDA-MB-231 cells. To induce maximal invasion under hypoxic conditions, limited amounts of TIMP-2 were needed as predicted by the ternary complex activation model (Wang et al., 2000) . These results define a key role for the MT1-MMP/TIMP-2/ MMP-2 ternary complex in hypoxia-induced cell invasion. In the tumor microenvironment, soluble MMPs, including pro-MMP-2, are produced by stromal cells (Hewitt and Dano, 1996; Saad et al., 2002; Hofmann et al., 2005) . In this respect, it has also been shown that utilization of pro-MMP-2 by many different breast cancer cell lines is limited by its activation rather than expression alone (Azzam et al., 1993) . In the experiments performed in our studies, serum was a significant source of pro-MMP-2. Thus, in cancer cells expressing MT1-MMP, hypoxia-induced invasion may be largely determined by pro-MMP-2 availability within the tumor microenvironment as well as by MT1-MMP activation mechanisms.
Several reports have suggested that hypoxia can regulate MT1-MMP at the transcriptional level in different cell systems (Ben-Yosef et al., 2002; Annabi et al., 2003; Ottino et al., 2004) . A study in renal carcinoma cells deficient in the tumor suppressor von Hippel Lindau (VHL) protein and expressing high levels of endogenous HIF-2a showed induction of MT1-MMP expression at the transcriptional level (Petrella et al., 2005) . Moreover, two putative HIF-binding sites have been found in the MT1-MMP promoter. Despite these observations, we did not observe regulation of MT1-MMP at the steady-state mRNA or total protein levels by hypoxic conditions in either breast carcinoma cell line. Our results show that hypoxia can modulate MT1-MMP function by inducing its localization to the plasma membrane of invadopodial projections and facilitating the assembly of the activation cascade. Thus, in some cell types, expression of MT1-MMP and local tumor microenvironment may be independent or synergistic mechanisms that promote tumor cell invasion.
Plasma membrane localization and vesicular trafficking are important mechanisms for MT1-MMP functional regulation. Exposure to concavalin A, a potent activator of MMP-2, can induce translocation of MT1-MMP from trans-Golgi network/endosomes to the plasma membrane (Zucker et al., 2002) . Furthermore, the dynamic turnover of MT1-MMP by internalization in clathrin-coated vesicles, endosome targeting and degradation processes have all been shown to be key for proper regulation of enzyme function at the cell membrane during cell migration and invasion (Jiang et al., 2001; Remacle et al., 2003; Takino et al., 2003; Wang et al., 2004) . Interestingly, Deschamps et al. (2005) showed in a model of ischemia/reperfusion that MT1-MMP was translocated to the cell membrane during the reoxygenation period, indicating that anoxia and/or reactive oxygen stress contributes to MT1-MMP trafficking. Our study provides evidence that chronic hypoxia induces cellular responses that promote MT1-MMP localization to the plasma membrane in human breast carcinoma cell lines and tumors.
Interestingly, protein trafficking to the plasma membrane has been identified as a novel cellular response to hypoxia. Hypoxia stimulates cell invasion by stabilizing microtubules and promoting a6b4 integrin trafficking to the plasma membrane, a requirement for cell migration during invasion (Yoon et al., 2005) . Thus, hypoxiadependent MT1-MMP localization to the plasma membrane combined with facilitated integrin function could provide a synergistic mechanism for tumor cell invasion and migration.
Organization of the cytoskeleton is important in regulating organelle and protein transport to the plasma membrane and in defining cell polarity. Cytoskeleton reorganization requires local assembly of signaling complexes of the Rho-family of small GTPases (Rho, Cdc42 and Rac1), which coordinate machinery for actin filament formation and expansion of protein scaffolds (Nelson, 2003; Symons and Rusk, 2003) . Furthermore, different lines of evidence point toward the Rho family as necessary signaling components for motility in a variety of carcinoma cell lines, as well as contributing factors to the invasive phenotype (Oxford and Theodorescu, 2003) . For example, in stromal cell-derived factor-1a-driven motility, the Rho-GTPases are clearly required for MT1-MMP activity (Bartolome et al., 2004) . Interestingly, it has been demonstrated that hypoxia induces a multitude of cellular responses that are Rho-dependent (Turcotte et al., , 2004 Bailly et al., 2004) . RhoA is overexpressed in the highly invasive MDA-MB-231 cells (Fritz et al., 1999) and our results suggest significant activation of RhoA by hypoxia. On the other hand, dominant-negative expression of RhoA in MDA-MB-231 cells specifically blocked the hypoxia-induced invasion and plasma membrane localization of MT1-MMP, confirming a role for this GTPase in cellular adaptation to hypoxia.
This study has defined MT1-MMP as an essential component of hypoxia-induced invasion in breast cancer cells. The mechanisms of this induction include posttranslational trafficking and activation of MT1-MMP at the surface of invadopodia. Therefore, hypoxia is a critical element that contributes to cellular metastatic potential within tumor microenvironments. We have also shown that, in human breast tumors, hypoxic microenvironments correlate with MMP-2 activity without apparent regulation of MT1-MMP at the protein level but with apparent localization to the cell membrane. The concept that large tumors, including breast tumors, may have internal hypoxic microenvironments that selectively induce cellular invasive properties via MT1-MMP and MMP-2 activation mechanisms suggests a link between primary tumor size and metastatic events.
Materials and methods
Cell culture and transfection MDA-MB-231 and MDA-MB-435 cell lines were cultured in DMEM supplemented with 10% FBS (Invitrogen). T47-D cells were grown in MEM supplemented with insulin (0.01 mg/ ml) (Sigma-Aldrich) and 10% FBS. When cells reached 90% confluency, they were switched to media containing 1% FBS prior to treatment. The full-length human MT1-MMP cDNA (Accesion # NM004995) was cloned into pcDNA4/TO (Invitrogen). Transfections of breast cancer cell lines were performed using Lipofectaminet Reagent (Invitrogen).
Reagents Llomastat (GM6001) was obtained from Chemicon. Aprotinin, bestatin and E64 were purchased from Sigma. Recombinant human TIMP-1, TIMP-2 and pro-MMP-2 were obtained from Chemicon. Blocking rabbit polyclonal anti-human MT1-MMP antibody (AB8102) and mouse monoclonal anti-human MMP-2 antibody (MAB13405) were purchased from Chemicon. Blocking mouse anti-human-CD13 (Coulter) was a gift from Dr Linda Shapiro (University of Connecticut Health Center, Farmington, CT, USA). For detection of MT1-MMP by immunofluorescence, immunohistochemistry or immunoblotting, a rabbit polyclonal antibody against the hinge domain was used (AB815, Chemicon). For immuno-electron microscopy, a mouse anti-human-MT1-MMP monoclonal antibody (MAB3319) and rabbit anti-human-TIMP-2 were used (Chemicon). Antibodies against Glut-1 and b-actin were obtained from Santa Cruz. EMA antibody was purchased from Dakocytomation (Denmark). Mouse anti-human RhoA and Rac1 were obtained from Santa Cruz and BD Transduction Laboratories, respectively. CD31 and CA-IX antibodies were purchased from Santa Cruz and Novus Biologicals, respectively.
Hypoxia treatment
Cells were placed in a CO 2 -AUTO-ZERO incubator (Model B5061, EK/CO 2 ; Heraeus, Germany) calibrated to maintain a hypoxic atmosphere of 1.5% O 2 , 5% CO 2 and 93.5% N 2 by continuous flow of nitrogen. A standard tissue culture incubator was used for a normoxic environment (21% O 2 , 5% CO 2 ).
Cell invasion assays
Invasion assays were performed in Transwell chambers (Corning). The 8-mm pore membranes of the upper chambers were coated with 50 mg of Matrigelt (Becton Dickenson, Germany) and placed in a well with DMEM containing 10% FBS. Cells (1 Â 10 4 ) were seeded into the upper chamber in media containing 1% FBS. For serum-free experiments, chambers were placed in wells containing OptiMEM TR (Invitrogen), and cells were seeded into the upper chambers in serum-free DMEM. After 24 h of incubation in normoxia or hypoxia, cells were removed from the top surface of the chamber and filters were fixed with formalin. Cells on the lower surface of the filter were stained with a 0.5% solution of crystal violet and the surface was photographed under a dissecting microscope (Stemi SV 11, Zeiss). Cells were counted from the digitized images using Image-Pro Plus (Media Cybernetics). All assays were performed in triplicate. Statistical analysis of the data was performed with Instat statistical package using appropriate Student's t-test comparisons; Pp0.05 was considered significant.
Gelatin zymography
Cell conditioned media (1% FBS) were concentrated 20 times using Amicon centricon-10 concentrators (Amicon) and resolved on a 10% nondenaturing polyacrylamide gel containing 1 mg/ml gelatin (Bio-Rad). For gelatin zymography of human tumor samples, protein lysates were directly loaded (30 mg) after normalization for total protein concentration. The resolved gels were soaked in 2.5% Triton X-100 for 1 h and then developed at 371C overnight in 50 mM Tris-HCl, pH 7.6, containing 150 mM NaCl, 10 mM CaCl 2 , and 10 mM ZnCl 2 . Gels were stained with Coomassie Blue R 250 (Bio-Rad) for 2 h and distained to define signal as clear bands. Gels were photographed using a Kodak Image Station 2000 MM .
RNA interference MDA-MB-231 cells were transiently transfected with 200 nM of siRNA duplexes targeting: MT1-MMP (5 0 -GGCCGACAU CAUGAUCUUCUU-3 0 ; 5 0 -GAAGAUCAUGAUGUCGGC CUU-3 0 ) using Oligofectaminet reagent (Invitrogen). Following recovery in complete medium, qRT-PCR, immunoblot and zymography analysis were performed on the samples to confirm inhibition.
Immunoblotting
Cell lysates were prepared from cells or from human breast cancer tissue by lysing with Triton-X-100 lysis buffer (50 mM Hepes, pH 7.5, 10 mM sodium pyrophosphate, 150 mM NaCl, 100 mM NaF, 0.2 mM NaOVa 4 , 1 mM EGTA, 1.5 mM MgCl 2 , 1% Triton X-100 and 10% glycerol). Lysates were separated by 10% SDS-PAGE and transferred to Nitrocellulose membranes (Bio-Rad). For MT1-MMP blots, anti-MT1-MMP antibodies were detected using biotinylated, rabbit anti-IgG secondary antibody (Vector Laboratories), followed by peroxidase-labeled streptavidin (KPL). Immunoblotting for b-actin was used for protein loading control.
Total RNA isolation and Northern blot analysis RNA was isolated from cells using the RNAeasy Kit (Qiagen). Northern blots of 5 mg RNA were performed as described previously (Claffey et al., 1996) . The DNA probes used were the hMT1-MMP coding region (Genbank Accession # NM004995), hGlut-1 coding region (Genbank Accession # NM006516), and the ribosome-associated protein, 36B4, as loading control. Blots were exposed to X-ray film (Kodak XOmat AR) and subjected to phosphorimage quantification (Molecular Dynamics). MT1-MMP and Glut-1 signals were normalized to 36B4 signals from the same lane.
Reverse transcription and qRT-PCR Total RNA (1 mg) was reversed transcribed using BD Sprintt PowerScriptt reverse transcriptase master mix (BD Biosience). Primers were designed using Primer Expresst 2.0 (Applied Biosystems). Primer sequences were as follows: cyclophilin A forward (5 0 -CTGGACCCAACACAAATGGTT-3 0 ) and reverse (5 0 -CCACAAtATTCATGCCTTCTTTCA-3 0 ), MT1-MMP forward (5 0 -GCAGAAGTTTTACGGCTTGCAA-3 0 ) and reverse (5 0 -CCTTCGAACATTGGCCTTGAT-3 0 ). Realtime PCR was performed using QuantiTect SYBR Green PCR kit (Qiagen) on an ABI Prism 7900 HT Sequence Detection System (PE Applied Biosystems). Each reaction was run in duplicate and quantified as previously described using normalization to cyclophilin A signal (Liu and Saint, 2002) .
Cell surface fluorescent immunocytochemistry
Cell surface labeling of MT1-MMP was performed as described previously (Wang et al., 2004) . Briefly, cells were seeded on glass coverslips and grown to confluency. Cells were fed medium containing 1% FBS and incubated for 24 h under normoxia or hypoxia. Cell surface MT1-MMP was labeled by incubating cells at 41C with primary polyclonal antibodies in 1.5% BSA/PBS for 2 h. Coverslips were fixed with 4% paraformaldehyde/PBS and then blocked with 3% BSA/PBS. Alexa 568-conjugated secondary antibodies (Molecular Probes) were added and incubated at room temperature. Slides were then mounted with glycerol:PBS containing 1 mg/ml DAPI (Molecular Probes) and photographed using confocal microscopy (Zeiss LSM510).
Immuno-electron microscopy Cells were plated onto Matrigel-coated transwell chambers in DMEM/1% FBS. Bottom chambers were filled with DMEM/ 10% FBS and placed in normoxia or hypoxia incubators for 24 h. Filters were fixed with 4% paraformaldehyde/PBS and then blocked in 3% BSA/PBS. Primary antibodies against MT1-MMP and TIMP-2 were added and incubated overnight at 41C. Filters were bound to anti-mouse 10 nm Au conjugate for MT1-MMP antibody detection and anti-rabbit 5 nm Au conjugate for TIMP-2 antibody detection. Filters were fixed in 2% glutaraldehyde/Na Cacodylate buffer and processed for osmium tetroxide post-fixation, block-stained with uranyl acetate (0.5% in H 2 O), serially dehydrated with ethanol and embedded in Polybed (Polysciences). Analysis of cross sections was performed by transmission electron microscopy on a Philips CM10. Serial sections were obtained and aligned onto a strip grid and identical locations photographed over 3-5 sections 70-90 nm thick. Quantification of positive immunostaining was performed on at least three serial sections at Â 72 000 magnification from at least three immunostained normoxic or hypoxic filters.
Cell surface biotinylation and MT1-MMP detection Cell surface biotinylation was performed as described previously (Zucker et al., 2002 (Zucker et al., , 2004 . Cell lysates were centrifugated at 13 000 g for 15 min at 41C. The supernatants were incubated with protein A sepharose beads (Bio-Rad) for 16 h at 41C to remove nonspecific proteins and immunoprecipitated with a mixture of rabbit polyclonal MT1-MMP antibodies against the hinge and the catalytic domain. The mixture was added to Protein A sepaharose beads. Washed beads were resuspended in SDS buffer and run in a 10% SDS-PAGE gel. After blotting, biotinylated surface MT1-MMP was detected with streptavidin-horse radish peroxidase (KPL).
To assess the efficiency of the surface biotinylation, lysates were incubated with washed streptavidin beads (Bio-Rad) at 41C for 16 h. Bound proteins were recovered by gentle centrifugation, washed, resuspended in SDS buffer and run in SDS gels. Total biotinylated samples were immunoblotted for Glut-1 and EMA.
Adenoviral transduction
Adenoviral constructs were obtained from Dr William Sessa (Yale University, New Haven, CT, USA). MDA-MB-231 cells were infected with 200 MOI of adenovirus containing the dominant-negative N19 Rho or dominant-negative N17 Rac1 under the control of the Tet repressor binding domain (Kalman et al., 1999) . The Tet repressor adenovirus was cotransfected with the dominant-negative adenoviral constructs in the presence of tetracycline (2 mg/ml; Invitrogen). After 24 h, tetracycline was removed to allow expression of dominant-negative mutants. Cells were used for immunohistochemistry and invasion assays.
Affinity precipitation of Rho-GTP After hypoxia treatment, MDA-MB-231 cells were lysed in RIPA buffer and 500 mg of lysates was incubated with GST-C21 (Rho inding domain of Rhotekin, kindly provided by Dr Shuh Narumiya, Kyoto University, Japan) beads, as described (Paik et al., 2001) . Equal loading was confirmed by blotting against b-actin.
Human breast cancer samples analysis Primary breast tumor slices were obtained within 10 min of resection and immediately frozen in OCT media (ShandonLipshaw). Cryosections (8 mm) were obtained and post-fixed with methanol:acetone (1:1) at À201C for 10 min. Immunohistochemistry was performed for vascular staining (anti-CD31) and against CA-IX as a hypoxia marker. Slides were developed with biotinylated secondary antibodies and the ABC streptavidin-peroxidase (Vector Technologies) using diamino-benzyl as substrate. Slides were counterstained for nuclei using a light methyl green stain. Highly vascular and hypoxic areas represented by CD31 and CA-IX staining, respectively, were cored from the original OCT block using a 1 mm frozen copper core tube (Beecher Instruments). The cored tissue was processed for total protein by lysing with 1% Tx-100 lysis buffer and used directly for zymographic analysis and immunoblotting.
